714 related articles for article (PubMed ID: 21857074)
1. Treatment of inflammatory bowel disease (IBD).
Pithadia AB; Jain S
Pharmacol Rep; 2011; 63(3):629-42. PubMed ID: 21857074
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulators in inflammatory bowel disease: an emerging role for biologic agents.
Kemp R; Dunn E; Schultz M
BioDrugs; 2013 Dec; 27(6):585-90. PubMed ID: 23749336
[TBL] [Abstract][Full Text] [Related]
3. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
4. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of chronic inflammatory bowel diseases].
Beglinger C
Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
7. [Crohn disease and ulcerative colitis--newer therapeutic approaches].
Ewe K
Z Gastroenterol; 1993 Feb; 31(2):151-5. PubMed ID: 8096666
[TBL] [Abstract][Full Text] [Related]
8. Current therapeutic approaches in inflammatory bowel disease.
Sohrabpour AA; Malekzadeh R; Keshavarzian A
Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
[TBL] [Abstract][Full Text] [Related]
9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
10. Recent advances using immunomodulators for inflammatory bowel disease.
Nielsen OH; Bjerrum JT; Herfarth H; Rogler G
J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease Drugs: A Focus on Autophagy.
Hooper KM; Barlow PG; Stevens C; Henderson P
J Crohns Colitis; 2017 Jan; 11(1):118-127. PubMed ID: 27381462
[TBL] [Abstract][Full Text] [Related]
12. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease.
Bhat MA; Usman I; Dhaneshwar S
Curr Rev Clin Exp Pharmacol; 2024; 19(3):234-249. PubMed ID: 37859409
[TBL] [Abstract][Full Text] [Related]
13. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
[No Abstract] [Full Text] [Related]
14. Advances in biologic therapy for ulcerative colitis and Crohn's disease.
D'Haens G; Daperno M
Curr Gastroenterol Rep; 2006 Dec; 8(6):506-12. PubMed ID: 17105690
[TBL] [Abstract][Full Text] [Related]
15. Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease.
Nguyen GC; Harris ML; Dassopoulos T
Curr Gastroenterol Rep; 2006 Dec; 8(6):499-505. PubMed ID: 17105689
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.
Herrlinger KR; Diculescu M; Fellermann K; Hartmann H; Howaldt S; Nikolov R; Petrov A; Reindl W; Otte JM; Stoynov S; Strauch U; Sturm A; Voiosu R; Ammendola A; Dietrich B; Hentsch B; Stange EF
J Crohns Colitis; 2013 Sep; 7(8):636-43. PubMed ID: 23078909
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
[TBL] [Abstract][Full Text] [Related]
18. Phytochemicals and their potential usefulness in inflammatory bowel disease.
Somani SJ; Modi KP; Majumdar AS; Sadarani BN
Phytother Res; 2015 Mar; 29(3):339-50. PubMed ID: 25572840
[TBL] [Abstract][Full Text] [Related]
19. Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?
Fiorino G; Rovida S; Correale C; Malesci A; Danese S
Curr Drug Targets; 2010 Feb; 11(2):249-60. PubMed ID: 20210771
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.
Dubois-Camacho K; Ottum PA; Franco-Muñoz D; De la Fuente M; Torres-Riquelme A; Díaz-Jiménez D; Olivares-Morales M; Astudillo G; Quera R; Hermoso MA
World J Gastroenterol; 2017 Sep; 23(36):6628-6638. PubMed ID: 29085208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
